Tornier Receives FDA Clearance For The Salto Talaris™ Anatomic Ankle Prosthesis

MINNEAPOLIS--(BUSINESS WIRE)--Tornier, a global orthopaedic company and a leader in the market for extremity joint systems, today announced that its Salto Talaris™ anatomic ankle prosthesis has been cleared by the United States Food and Drug Administration (“FDA”) for commercial use by U.S. physicians. The Salto Talaris™ is a newly designed version of the Salto™ Ankle Prosthesis, which has been successfully implanted in Europe for the last 9 years.